China Taiwan Crises
Fill-Finish Manufacturing Market

Fill-Finish Manufacturing Market by Instruments (Systems {Stand alone, Integrated), by Machine Type {Automated, Manual))), by End User (CMO, Biopharmaceutical Company), by Product (Consumables (Prefilled Syringes (Glass, Plastic}, Vial), by Region, and Global Forecast 2022-2028

Report Id: SNS/HC/2587 | July 2022 | Region: Global | 130 Pages

Report Scope & Overview:

The Fill-Finish Manufacturing Market Size was valued at USD 8.58 billion in 2021 and is expected to reach USD 16.84 billion by 2028, and grow at a CAGR of  10.1% over the forecast period 2022-2028.

Fill and finish is the procedure of filling vials with vaccination and finishing the process of packaging the drug for distribution in the pharmaceutical industry. Many vaccine makers outsource the filling and finishing of their vaccines to third parties. Fill-finish processing follows upstream bio-processing, active agent synthesis by cell culture or fermentation, and downstream purification. This is when the end product has the most value and so has the most to lose if it fails. At this level of development, tried-and-true techniques are most commonly adopted. Risk, expense, and regulatory effort can all be introduced into bio-process operations through innovations.

Fill-Finish Manufacturing Market

This comprises filling and sealing within final containers, which increasingly include prefilled syringes and other delivery devices, as well as formulation, mixing, or other preparation of active agents into final form, It may consist of liquid or lyophilized powder

MARKET DYNAMICS:

KEY DRIVERS:

  • Increasing technological progress in fill-finish manufacturing processes and Biopharmaceutical industry expansion

  • Prefilled syringes are becoming more popular for parenteral dose forms.

RESTRAINTS:

  • The high expenses of isolators and RABS

  • Increase technological advances in fill-finish manufacturing processes that are tailored to suit market demand.

OPPORTUNITY:

  • The COVID-19 epidemic has benefited the fill-finish manufacturing industry.

  • Fill-finish processes are increasingly being outsourced.

CHALLENGES:

  • The difficulties of preserving sterility in fill-finish manufacturing procedures

IMPACT OF COVID-19:

Pharmaceutical and biotech businesses, as well as governments worldwide, are collaborating to tackle the COVID-19 outbreak. This is accomplished through assisting in the creation of vaccines in order to meet the challenges of the pharmaceutical supply chain. In addition, there are around 115 vaccine candidates and another 155 compounds in the R&D pipeline. Furthermore, routinely used medications such as hydroxychloroquine have shown a significant increase in demand for COVID-19 control. As many wealthy countries run out of the medicine, there is a spike in demand, which has created enormous prospects for makers of COVID-19 management drugs. As a result of the demand for COVID-19 vaccines and treatment medications, the pharmaceutical and biotechnology industries are expected to increase significantly in the next years.

The market is divided into consumables and instruments based on the product. Prefilled syringes, vials, cartridges, and other consumables such as ampoules, bottles, and IV bags are subdivided further within the consumables segment. The sector of instruments is further subdivided into machines and systems. Machines are further classified into automated, semi-automated, and manual machines. Systems, on the other hand, are further classified as standalone and integrated.

Consumables led the market in 2019 and are predicted to be the fastest-growing sector throughout the forecast period. This segment's substantial share and rapid expansion can be due mostly to rising demand for prefilled syringes, widespread use of vials in lyophilization, and the increasing usage of disposable packaging for pharmaceuticals.

Due to increased outsourcing of fill-finish manufacturing processes from small-sized bio-pharmaceutical enterprises and a growing number of new entrants in the biologics manufacturing market, the contract manufacturing organisations segment is projected to grow over the forecast period.

MARKET PLAYER

West Pharmaceutical Services, Inc., Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, Syntegon Technology GmbH, I.M.A., Stevanato Group. (IndustriaMacchineAutomatiche) S.p.A., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger& Co. GmbH, Becton, Dickson and Company

MARKET SEGMENTS:

by End User

  • CMO

  • Biopharmaceutical Company

by Product

  • Consumables

  • Instruments

Fill-Finish Manufacturing Market

REGIONAL ANALYSIS:

Europe, North America, Asia Pacific, LATAM, and MEA are the five key regions. Europe had the highest proportion of the worldwide market, followed by North America. Factors such as the emergence of the bio-similar market as a result of the patent expiration of key biologic products, the rising incidence of chronic disorders, and the increased focus of major players on expanding their presence in this region are driving the growth of the European fill-finish manufacturing industry.

During the projected period, the Asia Pacific region is expected to have the greatest CAGR, owing to general growth in the bio-pharmaceutical industry. Factors contributing to the growth of the APAC bio-pharmaceutical market include increased investments by CMOs and important bio-pharmaceutical businesses, increased government backing, advances in R&D infrastructure, and expertise and academic excellence in the APAC region.

REGIONAL COVERAGE:

  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America

Fill-Finish Manufacturing Market Report Scope
Report Attributes Details
Market Size in 2021 US$ 8.85 Billion
Market Size by 2028 US$ 16.84 Billion
CAGR CAGR of 10.1% From 2022 to 2028
Base Year 2021
Forecast Period 2022-2028
Historical Data 2017-2020
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • by Instruments (Systems {Stand alone, Integrated)
• by Machine Type {Automated, Manual)))
• by End User (CMO, Biopharmaceutical Company)
• by Product (Consumables (Prefilled Syringes (Glass, Plastic}, Vial)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles West Pharmaceutical Services, Inc., Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, Syntegon Technology GmbH, I.M.A., Stevanato Group. (IndustriaMacchineAutomatiche) S.p.A., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger& Co. GmbH, Becton, Dickson and Company
Key Drivers • Prefilled syringes are becoming more popular for parenteral dose forms.
RESTRAINTS • The high expenses of isolators and RABS
• Increase technological advances in fill-finish manufacturing processes that are tailored to suit market demand.


Frequently Asked Questions (FAQ) :


Table of Contents

 

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

 

2. Research Methodology

 

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

 

4. Impact Analysis

4.1 COVID 19 Impact Analysis

 

5. Value Chain Analysis

 

6. Porter’s 5 forces model

 

7.  PEST Analysis

 

8.fill-finish manufacturing market, by End User

8.1 CMO

8.2 Biopharmaceutical Company

 

9.fill-finish manufacturing market, by Product

9.1 Consumables

9.2 Instruments

 

10. Regional Analysis

10.1 Introduction

10.2 North America

10.2.1 USA

10.2.2 Canada

10.2.3 Mexico

10.3 Europe

10.3.1 Germany

10.3.2 UK

10.3.3 France

10.3.4 Italy

10.3.5 Spain

10.3.6 The Netherlands

10.3.7 Rest of Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 South Korea

10.4.3 China

10.4.4 India

10.4.5 Australia

10.4.6 Rest of Asia-Pacific

10.5 The Middle East & Africa

10.5.1 Israel

10.5.2 UAE

10.5.3 South Africa

10.5.4 Rest

10.6 Latin America

10.6.1 Brazil

10.6.2 Argentina

10.6.3 Rest of Latin America

 

11.Company Profiles

11.1 West Pharmaceutical Services, Inc.,

11.1.1 Financial

11.1.2 Products/ Services Offered

11.1.3 SWOT Analysis

11.1.4 The SNS view

11.2 Gerresheimer AG

11.3 Maquinaria Industrial Dara

11.4 Robert Bosch

11.5 Syntegon Technology GmbH,

11.6 I.M.A. (IndustriaMacchineAutomatiche) S.p.A.,

11.7 OPTIMA Packaging Group GmbH,

11.8 Bausch+Strobel, Groninger& Co. GmbH,

11.9 Becton, Dickson and Company,

11.10 Stevanato Group

 

12. Competitive Landscape

12.1 Competitive Benchmarking

12.2 Market Share analysis

12.3 Recent Developments

 

13. Conclusion

 

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of a good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach a stage wherein we can provide our clients best and most accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research as the name suggests is a research process wherein, we collect data through readily available information. In this process, we use various paid and unpaid databases to which our team has access and gather data through the same. This includes examining listed companies’ annual reports, Journals, SEC filling, etc. Apart from this, our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various universities as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content-specific facts that can be sued to solve specific problems. Since the collected data is fresh and first-hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply sides of the industry to make sure we land an accurate judgment and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses, and observation of on-field participants. The below-mentioned chart should give a better understanding of part 1 of the primary interview.

Part 2: In this part of the primary research the data collected via secondary research and part 1 of the primary research is validated with the interviews with individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence center, our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real-time.

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but is not limited to getting rid of the many typos, duplication of numbers, or missing any important information. The people involved in this process include technical content writers, research heads, and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.